You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海正藥業(600267.SH)2019年度業績扭虧為盈至9307.27萬元 擬10派0.5元
格隆匯 04-29 22:30

格隆匯4月29日丨海正藥業(600267.SH)發佈2019年年度報告,實現營業收入110.72億元,同比增長8.68%;歸屬於上市公司股東的淨利潤9307.27萬元,上年度為淨虧損4.92億元;歸屬於上市公司股東的扣除非經常性損益的淨利潤-25.21億元;基本每股收益0.10元,擬每10股派現金0.5元(含税)。

2019年,公司實現營業收入110.72億元,較去年同期增長8.68%,主要來源公司製劑銷售的增長,包括自產製劑銷售和引進推廣製劑藥品(包括輝瑞產品)銷售增加以及商業流通業務銷售增長。

公司歸屬於母公司淨利潤9307.27萬元,業績實現扭虧為盈,主要由於製劑業務板塊中自產製劑業務和引進推廣製劑業務銷售的增長帶來毛利貢獻的增加以及2019年度公司完成對子公司海正博鋭的股權重組交易以及其它非核心長期資產處置,並確認了相關收益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account